|
For patients who are not currently on an inhaled corticosteroid, whose disease severity warrants treatment with 2 maintenance therapies, including patients on non-corticosteroid maintenance therapy, the recommended starting dosage is ADVAIR DISKUS 100/50 twice daily. For patients on an inhaled corticosteroid, Table 5 provides the recommended starting dosage. The maximum recommended dosage is ADVAIR DISKUS 500/50 twice daily. For all patients it is desirable to titrate to the lowest effective strength after adequate asthma stability is achieved. Table 5. Recommended Dosages of ADVAIR DISKUS for Patients With Asthma Taking Inhaled Corticosteroids Text Continues Below

Current Daily Dose of Inhaled Corticosteroid Recommended Strength and Dosing Schedule of ADVAIR DISKUS Beclomethasone dipropionate 420 mcg 462-840 mcg 100/50 twice daily 250/50 twice daily Budesonide 400 mcg 800-1,200 mcg 1,600 mcg* 100/50 twice daily 250/50 twice daily 500/50 twice daily Flunisolide 1,000 mcg 1,250-2,000 mcg 100/50 twice daily 250/50 twice daily Fluticasone propionate inhalation aerosol 176 mcg 440 mcg 660-880 mcg * 100/50 twice daily 250/50 twice daily 500/50 twice daily Fluticasone propionate inhalation powder 200 mcg 500 mcg 1,000 mcg * 100/50 twice daily 250/50 twice daily 500/50 twice daily Triamcinolone acetonide 1,000 mcg 1,100-1,600 mcg 100/50 twice daily 250/50 twice daily * ADVAIR DISKUS should not be used for transferring patients from systemic corticosteroid therapy. ADVAIR DISKUS should be administered twice daily every day. More frequent administration (more than twice daily) or a higher number of inhalations (more than 1 inhalation twice daily) of the prescribed strength of ADVAIR DISKUS is not recommended as some patients are more likely to experience adverse effects with higher doses of salmeterol. The safety and efficacy of ADVAIR DISKUS when administered in excess of recommended doses have not been established. If symptoms arise in the period between doses, an inhaled, short-acting beta2-agonist should be taken for immediate relief. Patients who are receiving ADVAIR DISKUS twice daily should not use additional salmeterol or other inhaled, long-acting beta2-agonists (e.g., formoterol) for prevention of EIB, or for any other reason. Page: << Prev | 1 | 2 | 3 | 4 | Next >>
|